Dr Lyronne Olivier
Consultant Breast Surgeon
Medical Associates
Awareness of ‘Male Breast Cancer’ (MBC), is the pillar and the downfall of this rare diagnosis. It impacts the discovery and the necessary clinical management of this subset of breast cancer patients. Several stunned expressions are always observed on the faces of the audience when the mention of men with breast cancer arises. Knowledge of MBC is lacking within the general population. This article attempts to bridge the gap of unawareness amongst men and women, as well as highlight many key features of Male breast cancer.
While the diagnosis of breast cancer is synonymous with women and is the leading cause for female cancer related deaths, Male Breast Cancer is rare and accounts for fewer than 1 percent of all breast cancers. The average man’s risk for breast cancer in his lifetime is approximately one in 1000 versus one in eight for women. The diagnosis of MBC is generally associated with a poorer prognosis and overall survival when compared to Female Breast Cancer (FBC).
There are many myths and obscured narratives around Male Breast Cancer, so let’s tackle one by one.
1. “Men don’t have breast!”
The male anatomy interestingly has breast tissue but it is significantly reduced in comparison to females. Therefore, men also possess the potential for abnormal proliferation of breast cells and subsequently MBC. The male breast tissue is mostly concentrated behind the nipple leading to an increased prevalence of centrally located tumors. An increased propensity for skin involvement is also recognized because of the sparse amount of breast tissue in men. This directly results in a poorer prognosis when one compares MBC to FBC.
2. “Isn’t that a Women’s disease?”
The lack of public awareness and the rarity of this disease has direct consequences on the patient’s outcomes. The early presence of a breast lump maybe disregarded as an incident and ‘temporary ‘ finding. An insight of MBC may lend to urgent evaluation by a breast surgeon.
Researchers have demonstrated that low awareness amongst men is common and the main cause for a delay in diagnosis.
The presentation of MBC is quite similar to that of FBC with signs and symptoms such as skin tethering, dimpling, a firm breast lump, breast redness, nipple turning inward and retraction, nipple discharge and a lump within the armpit.
MBC diagnosis is also associated with the stigmatization that may affect one’s ‘Masculinity ‘. Being diagnosed with a disease known to females maybe perceived as reduced masculinity and the presence of femininity. The psychosocial impact of this perception can also have negative consequences on health seeking and clinical appraisal.
3. “Can male breast cancer even be diagnosed in T&T?”
Yes, we have diagnosed MBC here in T&T and one of our patients willingly shared his story. It’s important to note, the diagnosis of MBC is determined by the same principles of FBC: ‘Triple assessment’. This includes a thorough clinical history and examination, radiological investigations and a biopsy of breast tissue. Similar radiological investigations such as breast ultrasonography and mammography would be requested as in FBC.
Can we treat men with breast cancer?
YES!
The men undergo similar treatment and management protocols as per female counterparts. Mastectomy is the most common operation performed surgically. This procedure entails removal of the overlying breast skin, tissue and nipple with preservation of the underlying chest musculature. In general the body image impact is less when compared to women undergoing the similar procedure.
The treatment following surgical management is transposed from female patients since there is a paucity of research for MBC.
Increased awareness of male breast cancer by our fathers, brothers and male relatives is the pillar for MBC management. To improve the clinical care, it is imperative to increase awareness and an adaptation of support services, patient educational outreach and treatment strategies to meet the demands of Men.
Dr LYRONNE OLIVIER
Breast Surgical Oncologist
Consultant Oncoplastic and Reconstructive Breast Surgeon
Associate Lecturer UWI
Dr Olivier’s career and personal goals have been aligned with improving Breast disease and Breast cancer care in Trinidad and Tobago. From 2007, he has been in the field of surgery; and completed the Doctor of Medicine in Surgery to become Consultant Surgeon in 2016. Dr Olivier was awarded the Prakash Scholarship by the University of Toronto, Canada in 2020 to pursue his Fellowship in Breast / Breast Surgical Oncology. He is a fellow of the Caribbean Fellowship of Surgeons, American College of Surgeons, as well as a member of the American Society of Breast Surgeons.
He currently works as Consultant Breast Surgeon/General Surgeon in the public and private sector as well as Associate Lecturer in the Department of Clinical Surgical Sciences, UWI. Training of General Surgery residents in Breast Surgical Oncology is another passion of Dr Olivier.
